Bempedoic acid
Esperion
[]
 led trial by stephen nissen showing bempedoic acid lowering mace, ldl and hscrp in 30% secondary and 70% primary prevention large patients #acc23 
Multimodality Cardiac Imaging, #Echofirst, #WhyCMR, #YesCCT at Houston Methodist, TX. Associate PD of CV imaging fellowship. T + RT my own opinion